Inmode Ltd
NASDAQ:INMD

Watchlist Manager
Inmode Ltd Logo
Inmode Ltd
NASDAQ:INMD
Watchlist
Price: 15.71 USD -3.62% Market Closed
Market Cap: 1.1B USD

INMD's latest stock split occurred on Oct 1, 2021

The company executed a 2-for-1 stock split, meaning that for every share held, investors received 2 new shares.

Before the split, INMD traded at 159.45 per share. Afterward, the share price was about 78.85.

The adjusted shares began trading on Oct 1, 2021. This was INMD's 3rd stock split, following the previous one in May 7, 2007.

Last Splits:
Oct 1, 2021
2-for-1
May 7, 2007
5-for-4
Jun 22, 2006
5-for-4
Pre-Split Price
79.725 159.45
Post-Split Price
78.85
Before
After
Last Splits:
Oct 1, 2021
2-for-1
May 7, 2007
5-for-4
Jun 22, 2006
5-for-4

Inmode Ltd
Stock Splits History

INMD Stock Splits Timeline
Oct 1, 2021
Oct 1, 2021
Split 2-for-1
x2
Pre-Split Price
79.725 159.45
Post-Split Price
78.85
Before
After
May 7, 2007
May 7, 2007
Split 5-for-4
x1.25
Pre-Split Price
N/A
Post-Split Price
6.785
Before
After
Jun 22, 2006
Jun 22, 2006
Split 5-for-4
x1.25
Pre-Split Price
N/A
Post-Split Price
6.785
Before
After

Global
Stock Splits Monitor

Date Company Split Pre-Split Price Post-Split Price
Apr 1, 2025
I
Icon Energy Corp
NASDAQ:ICON
1-for-40
/40
0.0478 1.912 USD 1.79 1.79 USD
Apr 1, 2025
V
Vortex Energy Corp
CNSX:VRTX
1-for-10
/10
0.075 0.075 CAD 0.11 0.11 CAD
Apr 1, 2025
R
Resource Centrix Holdings Inc
CNSX:RECE
10-for-1
x10
2.4 0.24 CAD 0.24 0.24 CAD
Apr 1, 2025
V
Vortex Energy Corp
OTC:VTECF
1-for-10
/10
0.05 0.5 USD 0.0378 0.0378 USD
Mar 31, 2025
Utime Ltd
NASDAQ:WTO
1-for-10
/10
0.151 1.51 USD 1.58 1.58 USD
Load More

Inmode Ltd
Glance View

Economic Moat
None
Market Cap
1.1B USD
Industry
Health Care

InMode Ltd., founded in 2008, has emerged as a dynamic player in the field of minimally invasive aesthetic medical treatments. Born during a period where the health and beauty sectors were experiencing rapid technological innovation, the company quickly carved a niche for itself by addressing a clear market need: the rising demand for non-surgical procedures. At its heart, InMode merges the precision of medical technology with the principles of aesthetic enhancement. Its primary offerings revolve around radio-frequency-based devices that healthcare providers use to achieve results that traditionally required more invasive techniques. This includes skin tightening, fat reduction, and body contouring solutions, all tailored to meet the growing consumer appetite for treatments that carry less downtime and risk compared to conventional surgery. The company monetizes its expertise by manufacturing and selling these state-of-the-art devices to a diverse group of users, ranging from dermatologists and plastic surgeons to aesthetic practices. InMode's revenue streams are bolstered by not only the direct sale of these devices but also by ongoing client relationships through service agreements and consumable products that are essential for their machine operation. It is a model that ensures continuous engagement with their clients, providing both stability and growth in revenue. By focusing on innovation and efficacy, InMode has successfully captured a significant share of the aesthetic medical market, embodying a business strategy that combines cutting-edge technology with practical solutions to consumer needs.

INMD Intrinsic Value
25.03 USD
Undervaluation 37%
Intrinsic Value
Price
Back to Top